Askin Lutfu, Tanriverdi Okan, Turkmen Serdar
Department of Cardiology, Adiyaman Training and Research Hospital, Adiyaman, Turkey.
North Clin Istanb. 2020 Apr 9;7(3):305-310. doi: 10.14744/nci.2019.71135. eCollection 2020.
Cardiac troponin is the preferred biomarker for the diagnosis of the acute coronary syndrome (ACS), but many other diseases can be identified with elevated troponin levels in the absence of ACS. The recent development of a high-sensitive cardiac troponin T (hs-cTnT) assay permits the detection of very low levels of cTnT. The use of hs-cTnT assay has emerged as a tool for identifying high-risk individuals for primary preventive treatment and can detect subclinical injury in asymptomatic patients. Hs-cTnT analyses are generally related to ischemia in the literature. Thus, we made an evaluation of hs-cTnT analysis in non-coronary patients, which may contribute to the literature.
心肌肌钙蛋白是诊断急性冠状动脉综合征（ACS）的首选生物标志物，但在无ACS的情况下，许多其他疾病也可出现肌钙蛋白水平升高。高敏心肌肌钙蛋白T（hs-cTnT）检测方法的最新进展使得能够检测到极低水平的cTnT。hs-cTnT检测已成为识别初级预防治疗高危个体的工具，并且能够检测无症状患者的亚临床损伤。在文献中，hs-cTnT分析通常与缺血相关。因此，我们对非冠心病患者的hs-cTnT分析进行了评估，这可能会为该文献做出贡献。
